# The Effect of Tirzepatide on Menopausal Vasomotor Symptoms and Biological Aging in Post-menopausal Women With Obesity

> **NCT07218445** · PHASE4 · RECRUITING · sponsor: **Mayo Clinic** · enrollment: 40 (estimated)

## Conditions studied

- Obesity
- Menopause Hot Flashes

## Interventions

- **DRUG:** Tirzepatide
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07218445
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-04
- **Primary completion:** 2027-09-18
- **Final completion:** 2027-09-18
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-03-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07218445

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07218445, "The Effect of Tirzepatide on Menopausal Vasomotor Symptoms and Biological Aging in Post-menopausal Women With Obesity". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT07218445. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*